Vaccine success: study reports fall in HPV infections in women in England

Since the introduction of the human papilloma virus (HPV) vaccine in England in 2008, Public Health England (PHE; London, UK) have reported an 86% decrease in HPV infections in women aged 16–21. With these promising results, experts predict that the vaccine could eventually lead to the eradication of cervical cancer.

In a recent study, published in The Journal of Infectious Diseases, PHE scientists report the prevalence of HPV in women attending chlamydia screening between 2010 and 2016.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.


Leave A Comment